Reassessment of the benefit/risk-ratio of selective COX-2-inhibitors

Documenti analoghi

• Reassessment of the benefit/risk-ratio of selective COX-2-inhibitors
  di: U Klotz
  Pubblicazione: (2005-03-01)
• The Effect of Selectivity of Inhibitors to Cox-2 Enzyme on Hepatobiliary and Platelet Function in Patients with Osteoarthritis
  di: Ali M. Hadi, et al.
  Pubblicazione: (2010-01-01)
• Identification of Potential COX-2 Inhibitors for the Treatment of Inflammatory Diseases Using Molecular Modeling Approaches
  di: Pedro H. F. Araújo, et al.
  Pubblicazione: (2020-09-01)
• Evidence of use: A selective COX-2 inhibitor in the treatment of experimental chronic pancreatitis induced by Dibutyltin dichloride
  di: Sukhodolya Sergij, et al.
  Pubblicazione: (2015-06-01)
• In Silico Design and SAR Studies Evaluation of New Amide Compounds as COX-1 and 2 Inhibitors
  di: Radwan Khaleel
  Pubblicazione: (2026-06-01)